Cargando…

Hyperbaric oxygen therapy compared to pharmacological intervention in fibromyalgia patients following traumatic brain injury: A randomized, controlled trial

Fibromyalgia is a chronic pain syndrome with unsatisfactory response to current treatments. Physical trauma, including traumatic brain Injury (TBI) is among the etiological triggers. Hyperbaric Oxygen therapy (HBOT) is an intervention that combines 100% oxygen with elevated atmospheric pressure. HBO...

Descripción completa

Detalles Bibliográficos
Autores principales: Ablin, Jacob N., Lang, Erez, Catalogna, Merav, Aloush, Valerie, Hadanny, Amir, Doenyas-Barak, Keren, Finci, Shachar, Polak, Nir, Fishlev, Gregory, Korin, Calanit, Tzidky, Rachel Yehudit, Meir Genuth, Oshra, Efrati, Shai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004612/
https://www.ncbi.nlm.nih.gov/pubmed/36897850
http://dx.doi.org/10.1371/journal.pone.0282406
_version_ 1784904876782780416
author Ablin, Jacob N.
Lang, Erez
Catalogna, Merav
Aloush, Valerie
Hadanny, Amir
Doenyas-Barak, Keren
Finci, Shachar
Polak, Nir
Fishlev, Gregory
Korin, Calanit
Tzidky, Rachel Yehudit
Meir Genuth, Oshra
Efrati, Shai
author_facet Ablin, Jacob N.
Lang, Erez
Catalogna, Merav
Aloush, Valerie
Hadanny, Amir
Doenyas-Barak, Keren
Finci, Shachar
Polak, Nir
Fishlev, Gregory
Korin, Calanit
Tzidky, Rachel Yehudit
Meir Genuth, Oshra
Efrati, Shai
author_sort Ablin, Jacob N.
collection PubMed
description Fibromyalgia is a chronic pain syndrome with unsatisfactory response to current treatments. Physical trauma, including traumatic brain Injury (TBI) is among the etiological triggers. Hyperbaric Oxygen therapy (HBOT) is an intervention that combines 100% oxygen with elevated atmospheric pressure. HBOT has been applied as a neuro-modulatory treatment in central nervous system–related conditions. The current study investigated the utility of HBOT for TBI–related fibromyalgia. Fibromyalgia patients with a history of TBI were randomized to either HBOT or pharmacological intervention. HBOT protocol comprised 60 daily sessions, breathing 100% oxygen by mask at 2 absolute atmospheres (ATA) for 90 minutes. Pharmacological treatment included Pregabalin or Duloxetine. The primary outcome was subjective pain intensity on visual analogue scale (VAS); Secondary endpoints included questionnaires assessing fibromyalgia symptoms as well as Tc-99m-ECD SPECT brain imaging. Pain threshold and conditioned pain modulation (CPM) were also assessed. Results demonstrated a significant group-by-time interaction in pain intensity post-HBOT compared to the medication group (p = 0.001), with a large net effect size (d = -0.95) in pain intensity reduction following HBOT compared to medications. Fibromyalgia related symptoms and pain questionnaires demonstrated significant improvements induced by HBOT as well as improvements in quality of life and increase in pain thresholds and CPM. SPECT demonstrated significant group-by-time interactions between HBOT and medication groups in the left frontal and the right temporal cortex. In conclusion, HBOT can improve pain symptoms, quality of life, emotional and social function of patients suffering from FMS triggered by TBI. The beneficial clinical effect is correlated with increased brain activity in frontal and parietal regions, associated with executive function and emotional processing.
format Online
Article
Text
id pubmed-10004612
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-100046122023-03-11 Hyperbaric oxygen therapy compared to pharmacological intervention in fibromyalgia patients following traumatic brain injury: A randomized, controlled trial Ablin, Jacob N. Lang, Erez Catalogna, Merav Aloush, Valerie Hadanny, Amir Doenyas-Barak, Keren Finci, Shachar Polak, Nir Fishlev, Gregory Korin, Calanit Tzidky, Rachel Yehudit Meir Genuth, Oshra Efrati, Shai PLoS One Research Article Fibromyalgia is a chronic pain syndrome with unsatisfactory response to current treatments. Physical trauma, including traumatic brain Injury (TBI) is among the etiological triggers. Hyperbaric Oxygen therapy (HBOT) is an intervention that combines 100% oxygen with elevated atmospheric pressure. HBOT has been applied as a neuro-modulatory treatment in central nervous system–related conditions. The current study investigated the utility of HBOT for TBI–related fibromyalgia. Fibromyalgia patients with a history of TBI were randomized to either HBOT or pharmacological intervention. HBOT protocol comprised 60 daily sessions, breathing 100% oxygen by mask at 2 absolute atmospheres (ATA) for 90 minutes. Pharmacological treatment included Pregabalin or Duloxetine. The primary outcome was subjective pain intensity on visual analogue scale (VAS); Secondary endpoints included questionnaires assessing fibromyalgia symptoms as well as Tc-99m-ECD SPECT brain imaging. Pain threshold and conditioned pain modulation (CPM) were also assessed. Results demonstrated a significant group-by-time interaction in pain intensity post-HBOT compared to the medication group (p = 0.001), with a large net effect size (d = -0.95) in pain intensity reduction following HBOT compared to medications. Fibromyalgia related symptoms and pain questionnaires demonstrated significant improvements induced by HBOT as well as improvements in quality of life and increase in pain thresholds and CPM. SPECT demonstrated significant group-by-time interactions between HBOT and medication groups in the left frontal and the right temporal cortex. In conclusion, HBOT can improve pain symptoms, quality of life, emotional and social function of patients suffering from FMS triggered by TBI. The beneficial clinical effect is correlated with increased brain activity in frontal and parietal regions, associated with executive function and emotional processing. Public Library of Science 2023-03-10 /pmc/articles/PMC10004612/ /pubmed/36897850 http://dx.doi.org/10.1371/journal.pone.0282406 Text en © 2023 Ablin et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Ablin, Jacob N.
Lang, Erez
Catalogna, Merav
Aloush, Valerie
Hadanny, Amir
Doenyas-Barak, Keren
Finci, Shachar
Polak, Nir
Fishlev, Gregory
Korin, Calanit
Tzidky, Rachel Yehudit
Meir Genuth, Oshra
Efrati, Shai
Hyperbaric oxygen therapy compared to pharmacological intervention in fibromyalgia patients following traumatic brain injury: A randomized, controlled trial
title Hyperbaric oxygen therapy compared to pharmacological intervention in fibromyalgia patients following traumatic brain injury: A randomized, controlled trial
title_full Hyperbaric oxygen therapy compared to pharmacological intervention in fibromyalgia patients following traumatic brain injury: A randomized, controlled trial
title_fullStr Hyperbaric oxygen therapy compared to pharmacological intervention in fibromyalgia patients following traumatic brain injury: A randomized, controlled trial
title_full_unstemmed Hyperbaric oxygen therapy compared to pharmacological intervention in fibromyalgia patients following traumatic brain injury: A randomized, controlled trial
title_short Hyperbaric oxygen therapy compared to pharmacological intervention in fibromyalgia patients following traumatic brain injury: A randomized, controlled trial
title_sort hyperbaric oxygen therapy compared to pharmacological intervention in fibromyalgia patients following traumatic brain injury: a randomized, controlled trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004612/
https://www.ncbi.nlm.nih.gov/pubmed/36897850
http://dx.doi.org/10.1371/journal.pone.0282406
work_keys_str_mv AT ablinjacobn hyperbaricoxygentherapycomparedtopharmacologicalinterventioninfibromyalgiapatientsfollowingtraumaticbraininjuryarandomizedcontrolledtrial
AT langerez hyperbaricoxygentherapycomparedtopharmacologicalinterventioninfibromyalgiapatientsfollowingtraumaticbraininjuryarandomizedcontrolledtrial
AT catalognamerav hyperbaricoxygentherapycomparedtopharmacologicalinterventioninfibromyalgiapatientsfollowingtraumaticbraininjuryarandomizedcontrolledtrial
AT aloushvalerie hyperbaricoxygentherapycomparedtopharmacologicalinterventioninfibromyalgiapatientsfollowingtraumaticbraininjuryarandomizedcontrolledtrial
AT hadannyamir hyperbaricoxygentherapycomparedtopharmacologicalinterventioninfibromyalgiapatientsfollowingtraumaticbraininjuryarandomizedcontrolledtrial
AT doenyasbarakkeren hyperbaricoxygentherapycomparedtopharmacologicalinterventioninfibromyalgiapatientsfollowingtraumaticbraininjuryarandomizedcontrolledtrial
AT fincishachar hyperbaricoxygentherapycomparedtopharmacologicalinterventioninfibromyalgiapatientsfollowingtraumaticbraininjuryarandomizedcontrolledtrial
AT polaknir hyperbaricoxygentherapycomparedtopharmacologicalinterventioninfibromyalgiapatientsfollowingtraumaticbraininjuryarandomizedcontrolledtrial
AT fishlevgregory hyperbaricoxygentherapycomparedtopharmacologicalinterventioninfibromyalgiapatientsfollowingtraumaticbraininjuryarandomizedcontrolledtrial
AT korincalanit hyperbaricoxygentherapycomparedtopharmacologicalinterventioninfibromyalgiapatientsfollowingtraumaticbraininjuryarandomizedcontrolledtrial
AT tzidkyrachelyehudit hyperbaricoxygentherapycomparedtopharmacologicalinterventioninfibromyalgiapatientsfollowingtraumaticbraininjuryarandomizedcontrolledtrial
AT meirgenuthoshra hyperbaricoxygentherapycomparedtopharmacologicalinterventioninfibromyalgiapatientsfollowingtraumaticbraininjuryarandomizedcontrolledtrial
AT efratishai hyperbaricoxygentherapycomparedtopharmacologicalinterventioninfibromyalgiapatientsfollowingtraumaticbraininjuryarandomizedcontrolledtrial